Use of apparent diffusion coefficient as a response biomarker in bone: Effect of developing sclerosis on quantified values

Skeletal Radiology

Volumn 43, Issue 2, 2014, Pages 205-208

  Messiou, C ^a,c   Collins, D J ^a   Morgan, V A ^a   Bianchini, D ^a   De Bono, J S ^a,b   De Souza, N M ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Bone; Diffusion; Magnetic resonance imaging; Metastases

Indexed keywords

ABIRATERONE ACETATE; BIOLOGICAL MARKER; DOCETAXEL; IOHEXOL; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTIC METHOD; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OSTEOSCLEROSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84891880186     PISSN: 03642348     EISSN: 14322161     Source Type: Journal    
DOI: 10.1007/s00256-013-1768-3     Document Type: Article

References (14)

1. Costelloe CM, Rohren EM, Madewell JE, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10(6):606-14.
2. Carlin BI, Andriole GL. The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer. 2000;88(12 Suppl):2989-94. (Pubitemid 30413181)
3. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228-47.
4. Lecouvet FE, Larbi A, Pasoglou V, et al. MRI for response assessment in metastatic bone disease. Eur Rad. 2013;23:1986-97.
5. Messiou C, Collins DJ, Giles S, De Bono JS. Bianchini, de Souza NM. Assessing response in bone metastases in prostate cancer with diffusion weighted MRI. Eur Rad. 2011;21:2169-77.
6. Messiou C, de Souza NM. Diffusion weighted magnetic resonance imaging of metastatic bone disease: a biomarker for treatment response monitoring. Cancer Biomarkers. 2010;6:21-32.
7. Messiou C, Collins DJ, Morgan VA, de Souza NM. Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Rad. 2011;21(8):1713-8.
8. Pollen JJ, Witztum KF, Ashburn WL. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. AJR. 1984;142:773-6. (Pubitemid 14166610)
9. Messiou C, Cook G, Reid AH, Attard G, Dearnaley D, de Bono JS, et al. The CT flare response of metastatic bone disease in prostate cancer. Acta Radiol. 2011;52(5):557-61.
10. Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, et al. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 1999;17(11):3461-7. (Pubitemid 29517916)
11. Reese TG, Heid O, Weisskoff RM, Wedeen VJ. Reduction of eddy-current induced distortion in diffusion MRI using twice refocused spin echo. Magn Reson Med. 2003;49(1):177-82. (Pubitemid 36042349)
12. Padhani AR, Liu G, Mu-Koh D, et al. Diffusion weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11:102-25.
13. Mundinger A, Wiesmeier B, Dinkel E, Helwig A, Beck A, Schulte Moenting J. Quantitative image analysis of vertebral body architecture-improved diagnosis in osteoporosis based on high-resolution computed tomography. Br J Radiol. 1993;66(783):209-13. (Pubitemid 23096973)
14. Park SH, Kim SJ, Park BC, Suh KJ, Lee JY, Park CW, et al. Three-dimensional osseous micro-architecture of the distal humerus: implications for internal fixation of osteoporotic fracture. J Should Elb Surg. 2010;19(2):244-50.